Researchers have significantly improved its progress of an innovative treatment for ATTR-CM, leveraging the compound. Early patient data suggests significant improvements for patients affected with this debilitating https://biotech182105.blogsidea.com/48966287/bridgebio-advances-amyloidosis-therapy-using-the-therapy